IBDEI1E4 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24642,2)
 ;;=^303317
 ;;^UTILITY(U,$J,358.3,24643,0)
 ;;=427.69^^140^1518^14
 ;;^UTILITY(U,$J,358.3,24643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24643,1,2,0)
 ;;=2^427.69
 ;;^UTILITY(U,$J,358.3,24643,1,5,0)
 ;;=5^PVC
 ;;^UTILITY(U,$J,358.3,24643,2)
 ;;=^87804
 ;;^UTILITY(U,$J,358.3,24644,0)
 ;;=443.9^^140^1518^15
 ;;^UTILITY(U,$J,358.3,24644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24644,1,2,0)
 ;;=2^443.9
 ;;^UTILITY(U,$J,358.3,24644,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,24644,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,24645,0)
 ;;=309.81^^140^1518^13
 ;;^UTILITY(U,$J,358.3,24645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24645,1,2,0)
 ;;=2^309.81
 ;;^UTILITY(U,$J,358.3,24645,1,5,0)
 ;;=5^PTSD
 ;;^UTILITY(U,$J,358.3,24645,2)
 ;;=^114692
 ;;^UTILITY(U,$J,358.3,24646,0)
 ;;=V66.7^^140^1518^2
 ;;^UTILITY(U,$J,358.3,24646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24646,1,2,0)
 ;;=2^V66.7
 ;;^UTILITY(U,$J,358.3,24646,1,5,0)
 ;;=5^PALLIATIVE CARE
 ;;^UTILITY(U,$J,358.3,24646,2)
 ;;=^89209
 ;;^UTILITY(U,$J,358.3,24647,0)
 ;;=577.0^^140^1518^3
 ;;^UTILITY(U,$J,358.3,24647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24647,1,2,0)
 ;;=2^577.0
 ;;^UTILITY(U,$J,358.3,24647,1,5,0)
 ;;=5^PANCREATITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,24647,2)
 ;;=^2643
 ;;^UTILITY(U,$J,358.3,24648,0)
 ;;=332.0^^140^1518^4
 ;;^UTILITY(U,$J,358.3,24648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24648,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,24648,1,5,0)
 ;;=5^PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,24648,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,24649,0)
 ;;=420.91^^140^1518^5
 ;;^UTILITY(U,$J,358.3,24649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24649,1,2,0)
 ;;=2^420.91
 ;;^UTILITY(U,$J,358.3,24649,1,5,0)
 ;;=5^PERICARDITIS
 ;;^UTILITY(U,$J,358.3,24649,2)
 ;;=^269695
 ;;^UTILITY(U,$J,358.3,24650,0)
 ;;=462.^^140^1518^6
 ;;^UTILITY(U,$J,358.3,24650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24650,1,2,0)
 ;;=2^462.
 ;;^UTILITY(U,$J,358.3,24650,1,5,0)
 ;;=5^PHARYNGITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,24650,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,24651,0)
 ;;=451.2^^140^1518^7
 ;;^UTILITY(U,$J,358.3,24651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24651,1,2,0)
 ;;=2^451.2
 ;;^UTILITY(U,$J,358.3,24651,1,5,0)
 ;;=5^PHLEBITIS
 ;;^UTILITY(U,$J,358.3,24651,2)
 ;;=^269813
 ;;^UTILITY(U,$J,358.3,24652,0)
 ;;=511.9^^140^1518^8
 ;;^UTILITY(U,$J,358.3,24652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24652,1,2,0)
 ;;=2^511.9
 ;;^UTILITY(U,$J,358.3,24652,1,5,0)
 ;;=5^PLEURAL EFFUSION NOS
 ;;^UTILITY(U,$J,358.3,24652,2)
 ;;=^123973
 ;;^UTILITY(U,$J,358.3,24653,0)
 ;;=511.0^^140^1518^9
 ;;^UTILITY(U,$J,358.3,24653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24653,1,2,0)
 ;;=2^511.0
 ;;^UTILITY(U,$J,358.3,24653,1,5,0)
 ;;=5^PLEURISY
 ;;^UTILITY(U,$J,358.3,24653,2)
 ;;=^95432
 ;;^UTILITY(U,$J,358.3,24654,0)
 ;;=486.^^140^1518^10
 ;;^UTILITY(U,$J,358.3,24654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24654,1,2,0)
 ;;=2^486.
 ;;^UTILITY(U,$J,358.3,24654,1,5,0)
 ;;=5^PNEUMONIA,UNSPEC
 ;;^UTILITY(U,$J,358.3,24654,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,24655,0)
 ;;=698.9^^140^1518^11
 ;;^UTILITY(U,$J,358.3,24655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24655,1,2,0)
 ;;=2^698.9
 ;;^UTILITY(U,$J,358.3,24655,1,5,0)
 ;;=5^PRURITUS
 ;;^UTILITY(U,$J,358.3,24655,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,24656,0)
 ;;=696.1^^140^1518^12
 ;;^UTILITY(U,$J,358.3,24656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24656,1,2,0)
 ;;=2^696.1
 ;;^UTILITY(U,$J,358.3,24656,1,5,0)
 ;;=5^PSORIASIS
 ;;^UTILITY(U,$J,358.3,24656,2)
 ;;=^271917
 ;;
 ;;$END ROU IBDEI1E4
